DK163783D0 - Fremgangsmade til fremstilling af imidazolinderivater - Google Patents

Fremgangsmade til fremstilling af imidazolinderivater

Info

Publication number
DK163783D0
DK163783D0 DK1637/83A DK163783A DK163783D0 DK 163783 D0 DK163783 D0 DK 163783D0 DK 1637/83 A DK1637/83 A DK 1637/83A DK 163783 A DK163783 A DK 163783A DK 163783 D0 DK163783 D0 DK 163783D0
Authority
DK
Denmark
Prior art keywords
sub
preparation
imidazoline derivatives
procedure
sup
Prior art date
Application number
DK1637/83A
Other languages
English (en)
Other versions
DK160093B (da
DK160093C (da
DK163783A (da
Inventor
Michael Robin Stillings
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of DK163783D0 publication Critical patent/DK163783D0/da
Publication of DK163783A publication Critical patent/DK163783A/da
Publication of DK160093B publication Critical patent/DK160093B/da
Application granted granted Critical
Publication of DK160093C publication Critical patent/DK160093C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Lock And Its Accessories (AREA)
  • Vehicle Interior And Exterior Ornaments, Soundproofing, And Insulation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Paper (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK163783A 1982-04-17 1983-04-14 Analogifremgangsmaade til fremstilling af 2-(2-(1,4-benzodioxanyl))-2-imidazolderivater DK160093C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8211205 1982-04-17
GB8211205 1982-04-17

Publications (4)

Publication Number Publication Date
DK163783D0 true DK163783D0 (da) 1983-04-14
DK163783A DK163783A (da) 1983-10-18
DK160093B DK160093B (da) 1991-01-28
DK160093C DK160093C (da) 1991-06-24

Family

ID=10529762

Family Applications (1)

Application Number Title Priority Date Filing Date
DK163783A DK160093C (da) 1982-04-17 1983-04-14 Analogifremgangsmaade til fremstilling af 2-(2-(1,4-benzodioxanyl))-2-imidazolderivater

Country Status (24)

Country Link
US (1) US4446148A (da)
EP (1) EP0092328B1 (da)
JP (1) JPS58192882A (da)
AT (1) ATE27275T1 (da)
AU (1) AU552397B2 (da)
CA (1) CA1190932A (da)
CS (1) CS233746B2 (da)
DD (1) DD209628A5 (da)
DE (1) DE3371631D1 (da)
DK (1) DK160093C (da)
ES (1) ES8405394A1 (da)
FI (1) FI73676C (da)
GB (1) GB2118548B (da)
GR (1) GR78528B (da)
HU (1) HU190894B (da)
IE (1) IE54922B1 (da)
IL (1) IL68318A (da)
NO (1) NO158019C (da)
NZ (1) NZ203680A (da)
PL (1) PL143658B1 (da)
PT (1) PT76558B (da)
SU (1) SU1217257A3 (da)
ZA (1) ZA832278B (da)
ZW (1) ZW8783A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882343A (en) * 1987-08-28 1989-11-21 G. D. Searle & Co. Biarylalkylimidazole derivatives as anti-depressants
AU6307690A (en) * 1989-09-27 1991-04-11 Rhone-Poulenc Sante Imidazoles
FR2698789B1 (fr) * 1992-12-07 1995-03-03 Pf Medicament Utilisation de l'idazoxan et ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson et de son évolution.
FR2700113B1 (fr) * 1993-01-07 1995-03-24 Pf Medicament Utilisation de l'Idazoxan et ses dérivés pour la fabrication de médicaments destinés au traitement des maladies neurodégénératives et en particulier l'évolution de la maladie d'Alzheimer.
US6162455A (en) * 1997-01-22 2000-12-19 American Cyanamid Company Method for increasing lean meat, improving the lean meat to fat ratio and improving amino acid utilization in warm-blooded animals
FR2766824B1 (fr) * 1997-07-30 1999-09-10 Adir Nouveaux composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2795727B1 (fr) * 1999-06-29 2001-09-21 Pf Medicament Nouveaux derives benzodioxanne imidazolines fluores, leur preparation et leurs applications en therapeutique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2979511A (en) * 1959-03-25 1961-04-11 Olin Mathieson Certain 1, 4-benzodioxanyl imidazolines and corresponding pyrimidines and process
PH16249A (en) * 1980-02-04 1983-08-16 Reckitt & Colmann Prod Ltd Imidazoline derivatives,its pharmaceutical composition and method of use
NZ199469A (en) * 1981-01-30 1984-03-16 Reckitt & Colmann Prod Ltd Benzodioxanyl-2-imidazoline derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
FI73676C (fi) 1987-11-09
CA1190932A (en) 1985-07-23
NZ203680A (en) 1985-08-16
AU1329883A (en) 1983-10-20
FI831199A0 (fi) 1983-04-11
DE3371631D1 (de) 1987-06-25
PT76558B (en) 1986-01-21
IE830858L (en) 1983-10-17
NO158019C (no) 1988-06-29
NO158019B (no) 1988-03-21
CS233746B2 (en) 1985-03-14
DK160093B (da) 1991-01-28
EP0092328B1 (en) 1987-05-20
PT76558A (en) 1983-05-01
AU552397B2 (en) 1986-05-29
PL241515A1 (en) 1984-07-30
FI73676B (fi) 1987-07-31
HU190894B (en) 1986-12-28
ATE27275T1 (de) 1987-06-15
ZW8783A1 (en) 1983-07-06
GR78528B (da) 1984-09-27
DK160093C (da) 1991-06-24
NO831318L (no) 1983-10-18
FI831199L (fi) 1983-10-18
IL68318A0 (en) 1983-07-31
PL143658B1 (en) 1988-03-31
GB2118548B (en) 1985-07-31
US4446148A (en) 1984-05-01
EP0092328A3 (en) 1985-05-08
JPH0427984B2 (da) 1992-05-13
IE54922B1 (en) 1990-03-28
EP0092328A2 (en) 1983-10-26
JPS58192882A (ja) 1983-11-10
GB2118548A (en) 1983-11-02
DD209628A5 (de) 1984-05-16
DK163783A (da) 1983-10-18
ZA832278B (en) 1983-12-28
ES521440A0 (es) 1984-06-01
ES8405394A1 (es) 1984-06-01
IL68318A (en) 1986-07-31
SU1217257A3 (ru) 1986-03-07

Similar Documents

Publication Publication Date Title
ATE35506T1 (de) Selektive methode zum blockieren von 5ht2 rezeptoren.
DK163783D0 (da) Fremgangsmade til fremstilling af imidazolinderivater
IT1196150B (it) Derivati di 1-(bis-(4-fluorofenil)metil)-4-(3-fenil-2-propenil)-esaidro-1h-1,4-diazepina ad attivita' calcio antagonista,sua preparazione e composizioni che lo contengono
ATE53025T1 (de) 7-(2-(dialkylamino)ethly>-4-hydroxy-1,3benzimidazol-2-one.
DK160556C (da) Benzodioxinpyrrolderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
ES2054234T3 (es) Un procedimiento para la preparacion de derivados indol.
FI821504A0 (fi) Aminocyklopentanolsyror och -estrar och deras framstaellning och farmaceutiska komposition
GB1480892A (en) 3-nitropyrazole derivatives
DK184484D0 (da) Fremgangsmaade til fremstilling af oralt velabsorberbare dosisenhedsformer af medicinsk virksomme 1,4-dihydropyridinderivater
MX9203542A (es) Agentes anti-ulcera de 2-(guanidino n-substituido)-4-heteroariltiazol.

Legal Events

Date Code Title Description
PBP Patent lapsed
PBP Patent lapsed